GKB Ophthalmics
48.76
-1.48(-2.95%)
Market Cap₹- Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-2.95%
1M-27.21%
6M-34.97%
1Y-52.50%
5Y-0.18%
View Company Insightsright
More news about GKB Ophthalmics
25Aug 25
Ace Investor Vijay Kedia Weighs In on GKB Ophthalmics Shareholder Controversy
Ace investor Vijay Kedia has commented on a recent incident involving GKB Ophthalmics Ltd and a shareholder, Abhishek Kalra. During the company's virtual AGM, Kalra criticized the management for poor stock performance and governance issues, demanding the Managing Director's resignation. Kedia condemned the harsh language used but supported the underlying message, emphasizing the importance of respecting shareholder money and holding incompetent managements accountable. The incident has sparked discussions about shareholder activism and corporate governance in India.
23Aug 25
GKB Ophthalmics Faces Shareholder Criticism at Virtual AGM
GKB Ophthalmics Ltd held its 43rd Annual General Meeting (AGM) virtually on August 21, 2025. The meeting was marked by controversy when shareholder Abhishek Kalra, owning one share, verbally attacked the company's management. Kalra criticized Managing Director Krishna Gopal Gupta's performance and demanded his resignation within 10 days. The confrontation occurred against a backdrop of weak stock performance, with shares declining 32.27% over the past year and 18.38% year-to-date. Despite the incident, the AGM proceeded with its agenda, passing several resolutions including financial statement adoption, director re-appointment, and approval of related party transactions. The meeting saw participation from 55 shareholders, with all resolutions passed by the requisite majority.
19Aug 25
Thakkers Group Reports 85% Revenue Surge in Q1, Net Profit Jumps 68%
Thakkers Group Limited, a real estate developer, reported strong Q1 results with total income rising 85.3% to Rs 791.88 lakhs and net profit increasing 68% to Rs 261.20 lakhs year-over-year. Earnings per share improved to Rs 16.50 from Rs 9.82. The company's reserves grew to Rs 5815.20 lakhs, while paid-up equity share capital remained at Rs 158.33 lakhs. However, revenue saw a slight sequential decline from the previous quarter.
GKB Ophthalmics
48.76
-1.48
(-2.95%)
1 Year Returns:-52.50%
Industry Peers
Fabtech Technologies
234.82
(+1.13%)
Osel Devices
725.00
(+1.58%)
Vasa Denticity
599.00
(+0.16%)
Laxmi Dental
275.50
(+10.69%)
Tarsons Products
227.89
(-1.70%)
Poly Medicure
1,910.80
(-0.32%)
Aprameya Engineering
318.55
(-3.44%)
Galaxy Medicare
20.75
(+4.80%)
Nureca
305.65
(+1.95%)